Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

The FDA granted priority review to rusfertide, a potential therapy for polycythemia vera; a decision regarding approval is ...

When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the industry.

In 1987, Zurich was a hotbed of radical feminism. For three Swiss francs (close to $6 today), left-wing bookstores sold a copy of a pamphlet called “Antisexistische Schrittversuche fuer die Aufloesung ...

Banning phones in schools has emerged as a rare bipartisan policy across America. As the school year begins, millions of students in 17 states, from New York to Kentucky, will be newly prohibited from ...

Rachel Feltman: For Scientific American’s Science Quickly, I’m Rachel Feltman. When it comes to birth control, men have exactly two reliable options: condoms or a vasectomy. That’s it. For decades ...

Men might finally get a chance to bench their swimmers. A first-of-its-kind male birth control pill just cleared its first human safety test, raising hopes that it could soon open the door to a new ...

Add Yahoo as a preferred source to see more of our stories on Google. Men might finally get a chance to bench their swimmers. A first-of-its-kind male birth control pill just cleared its first human ...

Malaria control and elimination is threatened by the spread of insecticide resistance and behavioral adaptation of vectors. Whether mass administration of ivermectin, a broad-spectrum antiparasitic ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Mifepristone reduced HbA1c and weight in patients with ...

Racial disparities on incidence and survival in Kaposi sarcoma during the post-retroviral era: A Surveillance, Epidemiology and End Results program database (2000-2021) retrospective analysis. This is ...

Phase III randomized placebo-controlled trial on repurposing olanzapine for prevention of radiotherapy-induced nausea and vomiting (RINV): CTRI/2022/01/039723. PNQ ≥D 3 months after end of PTX 32.0% ...